An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs

NCT07142655 · clinicaltrials.gov ↗
COMPLETED
Status
1500
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Bayer